RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 62 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $196,000 | -83.6% | 452,345 | -67.9% | 0.14% | -80.7% |
| Q2 2022 | $1,198,000 | -84.6% | 1,408,345 | 0.0% | 0.72% | -80.9% |
| Q1 2022 | $7,760,000 | -43.2% | 1,408,345 | -0.2% | 3.79% | -37.9% |
| Q4 2021 | $13,659,000 | -45.9% | 1,411,005 | -0.1% | 6.10% | -46.9% |
| Q3 2021 | $25,243,000 | -26.7% | 1,411,775 | 0.0% | 11.48% | -23.8% |
| Q2 2021 | $34,461,000 | -8.1% | 1,411,775 | -0.2% | 15.06% | -11.4% |
| Q1 2021 | $37,484,000 | +819.6% | 1,414,500 | +163.4% | 17.01% | +624.3% |
| Q4 2020 | $4,076,000 | +44.4% | 537,000 | -4.7% | 2.35% | +28.2% |
| Q3 2020 | $2,823,000 | -16.2% | 563,500 | 0.0% | 1.83% | -21.0% |
| Q2 2020 | $3,370,000 | +34.4% | 563,500 | 0.0% | 2.32% | +13.6% |
| Q1 2020 | $2,508,000 | -53.1% | 563,500 | 0.0% | 2.04% | -39.8% |
| Q4 2019 | $5,353,000 | – | 563,500 | – | 3.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |